These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21865412)

  • 41. The clinical course of multiple sclerosis.
    Confavreux C; Vukusic S
    Handb Clin Neurol; 2014; 122():343-69. PubMed ID: 24507525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of relapse phenotype recurrence in multiple sclerosis.
    Kalincik T; Buzzard K; Jokubaitis V; Trojano M; Duquette P; Izquierdo G; Girard M; Lugaresi A; Grammond P; Grand'Maison F; Oreja-Guevara C; Boz C; Hupperts R; Petersen T; Giuliani G; Iuliano G; Lechner-Scott J; Barnett M; Bergamaschi R; Van Pesch V; Amato MP; van Munster E; Fernandez-Bolanos R; Verheul F; Fiol M; Cristiano E; Slee M; Rio ME; Spitaleri D; Alroughani R; Gray O; Saladino ML; Flechter S; Herbert J; Cabrera-Gomez JA; Vella N; Paine M; Shaw C; Moore F; Vucic S; Savino A; Singhal B; Petkovska-Boskova T; Parratt J; Sirbu CA; Rozsa C; Liew D; Butzkueven H;
    Mult Scler; 2014 Oct; 20(11):1511-22. PubMed ID: 24777276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticipation of age at onset in familial multiple sclerosis.
    Romero-Pinel L; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Kremenchutzky M; Arbizu T
    Eur J Neurol; 2010 Apr; 17(4):572-5. PubMed ID: 20002735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis.
    Naseri A; Nasiri E; Sahraian MA; Daneshvar S; Talebi M
    Mult Scler Relat Disord; 2021 May; 50():102816. PubMed ID: 33571792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relation between menarche and the age of first symptoms in a multiple sclerosis cohort.
    Sloka JS; Pryse-Phillips WE; Stefanelli M
    Mult Scler; 2006 Jun; 12(3):333-9. PubMed ID: 16764348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dietary salt intake and time to relapse in paediatric multiple sclerosis.
    Nourbakhsh B; Graves J; Casper TC; Lulu S; Waldman A; Belman A; Greenberg B; Weinstock-Guttman B; Aaen G; Tillema JM; Hart J; Ness J; Rubin J; Krupp L; Gorman M; Benson L; Rodriguez M; Chitnis T; Rose J; Barcellos L; Waubant E;
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1350-1353. PubMed ID: 27343226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades.
    Romero-Pinel L; Bau L; Matas E; León I; Muñoz-Vendrell A; Arroyo P; Masuet-Aumatell C; Martínez-Yélamos A; Martínez-Yélamos S
    Mult Scler Relat Disord; 2022 Dec; 68():104103. PubMed ID: 36029708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Menarche increases relapse risk in pediatric multiple sclerosis.
    Lulu S; Graves J; Waubant E
    Mult Scler; 2016 Feb; 22(2):193-200. PubMed ID: 25948626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review.
    Kalincik T
    Neuroepidemiology; 2015; 44(4):199-214. PubMed ID: 25997994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.
    Spelman T; Gray O; Trojano M; Petersen T; Izquierdo G; Lugaresi A; Hupperts R; Bergamaschi R; Duquette P; Grammond P; Giuliani G; Boz C; Verheul F; Oreja-Guevara C; Barnett M; Grand'Maison F; Edite Rio M; Lechner-Scott J; Van Pesch V; Fernandez Bolanos R; Flechter S; Den Braber-Moerland L; Iuliano G; Amato MP; Slee M; Cristiano E; Saladino ML; Paine M; Vella N; Kasa K; Deri N; Herbert J; Moore F; Petkovska-Boskova T; Alroughani R; Savino A; Shaw C; Vucic S; Santiago V; Bacile EA; Skromne E; Poehlau D; Cabrera-Gomez JA; Lucas R; Butzkueven H
    Ann Neurol; 2014 Dec; 76(6):880-90. PubMed ID: 25283272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age is a critical determinant in recovery from multiple sclerosis relapses.
    Conway BL; Zeydan B; Uygunoğlu U; Novotna M; Siva A; Pittock SJ; Atkinson EJ; Rodriguez M; Kantarci OH
    Mult Scler; 2019 Nov; 25(13):1754-1763. PubMed ID: 30303037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of multiple sclerosis in Iraq: retrospective review of 4355 cases and literature review.
    Hassoun HK; Al-Mahadawi A; Sheaheed NM; Sami SM; Jamal A; Allebban Z
    Neurol Res; 2022 Jan; 44(1):14-23. PubMed ID: 34409919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case-control study of dietary salt intake in pediatric-onset multiple sclerosis.
    McDonald J; Graves J; Waldman A; Lotze T; Schreiner T; Belman A; Greenberg B; Weinstock-Guttman B; Aaen G; Tillema JM; Hart J; Lulu S; Ness J; Harris Y; Rubin J; Candee M; Krupp LB; Gorman M; Benson L; Rodriguez M; Chitnis T; Mar S; Barcellos LF; Laraia B; Rose J; Roalstad S; Simmons T; Casper TC; Waubant E
    Mult Scler Relat Disord; 2016 Mar; 6():87-92. PubMed ID: 27063630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Clinical and Epidemiological Profile of Paediatric-Onset Multiple Sclerosis in Poland.
    Brola W; Steinborn B; Żak M; Mazurkiewicz-Bełdzińska M; Jóźwiak S; Sobolewski P; Wilski M; Bilska M; Siedlarska M; Puzio-Bochen I; Wencel-Warot A; Lemka M; Kroczka S; Czyżyk E; Bocheńska M; Emich-Widera E; Pietruszewski J; Boćkowski L; Kapica-Topczewska K; Czarnowska A; Kułakowska A; Ujma-Czapska B; Gruna-Ożarowska A; Przysło Ł; Połatyńska K; Dudzińska M; Mitosek-Szewczyk K; Melnyk A; Adamczyk-Sowa M; Kotulska K
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic modifiers of multiple sclerosis progression, severity and onset.
    Sadovnick AD; Traboulsee AL; Zhao Y; Bernales CQ; Encarnacion M; Ross JP; Yee IM; Criscuoli MG; Vilariño-Güell C
    Clin Immunol; 2017 Jul; 180():100-105. PubMed ID: 28501589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and Epidemiological Aspects of Late Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-Based Study.
    Nasiri E; Naseri A; Abbasgholizadeh P; Fahidi A; Talebi M
    Arch Iran Med; 2022 Nov; 25(11):725-729. PubMed ID: 37543896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary progressive multiple sclerosis.
    Hawker K
    Continuum (Minneap Minn); 2010 Oct; 16(5 Multiple Sclerosis):211-25. PubMed ID: 22810607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early-Onset Multiple Sclerosis: Reports of 300 Patients from Iran.
    Omrani F; Sahraian MA; Saeen AA; Omrani Z; Hayeri G
    J Pediatr Neurosci; 2018; 13(2):137-140. PubMed ID: 30090125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex differences in multiple sclerosis.
    Crabtree-Hartman E
    Continuum (Minneap Minn); 2010 Oct; 16(5 Multiple Sclerosis):193-210. PubMed ID: 22810606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Features of multiple sclerosis in older patients in South Wales.
    White AD; Swingler RJ; Compston DA
    Gerontology; 1990; 36(3):159-64. PubMed ID: 2227469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.